Emodepside multiple ascending dose Phase I
NCT03383614 | United Kingdom
A phase 1 multiple-dose-escalation study to investigate safety, tolerability, and pharmacokinetics of emodepside after oral dosing in healthy male subjects.
Emodepside relative bioavailability study of immediate release tables and solutions Phase I
NCT03383523 | United Kingdom
This study evaluates 2 new immediate release-tablet formulations of emodepside and they will be compared to the oral liquid service formulation used in the emodepside single-ascending dose study.
Emodepside single ascending dose Phase I
NCT02661178 | United Kingdom | Completed
Emodepside single-ascending dose for onchocerciasis.
Last update: February 2018